ID

36669

Descripción

Pilot Study of a Novel Type of CT Scan to Assess Treatment Response During Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02053285

Link

https://clinicaltrials.gov/show/NCT02053285

Palabras clave

Versiones (1)
  1. 31/5/19 31/5/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

31 de mayo de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Non-small Cell Lung Cancer Stage III NCT02053285

Inglés

Eligibility Non-small Cell Lung Cancer Stage III NCT02053285

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients aged greater than 18 years with a diagnosis of stage iii non-small cell lung cancer.
Descripción

Age | Non-Small Cell Lung Carcinoma TNM clinical staging

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0007131
UMLS CUI [2,2]
C3258246
planned treatment with either definitive chemoradiotherapy or preoperative chemoradiotherapy followed by surgical resection.
Descripción

Chemoradiotherapy Planned | Chemoradiotherapy Preoperative Planned | Excision Planned

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0436307
UMLS CUI [1,2]
C1301732
UMLS CUI [2,1]
C0436307
UMLS CUI [2,2]
C0445204
UMLS CUI [2,3]
C1301732
UMLS CUI [3,1]
C0728940
UMLS CUI [3,2]
C1301732
pet-ct study within 4 weeks of next available dect study.
Descripción

PET/CT Study | DECT Study

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1699633
UMLS CUI [1,2]
C2603343
UMLS CUI [2,1]
C4055114
UMLS CUI [2,2]
C2603343
patients must have measurable primary and nodal disease, defined by at least one lesion (primary and lymph node) greater than 1 cm.
Descripción

Measurable Disease Primary | Disorder of lymph node Primary | Primary lesion Size Quantity | Lymph node Primary lesion Size Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C0205225
UMLS CUI [2,1]
C0272394
UMLS CUI [2,2]
C0205225
UMLS CUI [3,1]
C1402294
UMLS CUI [3,2]
C0456389
UMLS CUI [3,3]
C1265611
UMLS CUI [4,1]
C0024204
UMLS CUI [4,2]
C1402294
UMLS CUI [4,3]
C0456389
UMLS CUI [4,4]
C1265611
kidney function sufficient to tolerate iodine-based ct contrast.
Descripción

Renal function | CT iodinated contrast dye

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2,1]
C0040405
UMLS CUI [2,2]
C0879373
no allergy to iodine-based contrast.
Descripción

Iodine contrast allergy Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C4022917
UMLS CUI [1,2]
C0332197
ability to understand and the willingness to sign informed consent.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
participants with a prior history of thoracic radiotherapy.
Descripción

Radiotherapy to thorax

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4038705
participants may not be receiving any other study agents.
Descripción

Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013230
inability to tolerate ct contrast
Descripción

CT scan contrast Receive Unable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0742919
UMLS CUI [1,2]
C1514756
UMLS CUI [1,3]
C1299582
pregnant women are excluded from this study because radiotherapy has the potential for teratogenic or abortifacient effects. because there is an unknown but potential risk of adverse events in nursing infants secondary to treatment of the mother with radiotherapy, breastfeeding should be discontinued if the mother is treated with radiotherapy. these potential risks may also apply to other agents used in this study.
Descripción

Pregnancy | Breast Feeding To be stopped

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C0006147
UMLS CUI [2,2]
C1272691
Volver a la parte superior de la página

Similar models

Eligibility Non-small Cell Lung Cancer Stage III NCT02053285

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age | Non-Small Cell Lung Carcinoma TNM clinical staging
Item
patients aged greater than 18 years with a diagnosis of stage iii non-small cell lung cancer.
boolean
C0001779 (UMLS CUI [1])
C0007131 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
Chemoradiotherapy Planned | Chemoradiotherapy Preoperative Planned | Excision Planned
Item
planned treatment with either definitive chemoradiotherapy or preoperative chemoradiotherapy followed by surgical resection.
boolean
C0436307 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C0436307 (UMLS CUI [2,1])
C0445204 (UMLS CUI [2,2])
C1301732 (UMLS CUI [2,3])
C0728940 (UMLS CUI [3,1])
C1301732 (UMLS CUI [3,2])
PET/CT Study | DECT Study
Item
pet-ct study within 4 weeks of next available dect study.
boolean
C1699633 (UMLS CUI [1,1])
C2603343 (UMLS CUI [1,2])
C4055114 (UMLS CUI [2,1])
C2603343 (UMLS CUI [2,2])
Measurable Disease Primary | Disorder of lymph node Primary | Primary lesion Size Quantity | Lymph node Primary lesion Size Quantity
Item
patients must have measurable primary and nodal disease, defined by at least one lesion (primary and lymph node) greater than 1 cm.
boolean
C1513041 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
C0272394 (UMLS CUI [2,1])
C0205225 (UMLS CUI [2,2])
C1402294 (UMLS CUI [3,1])
C0456389 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
C0024204 (UMLS CUI [4,1])
C1402294 (UMLS CUI [4,2])
C0456389 (UMLS CUI [4,3])
C1265611 (UMLS CUI [4,4])
Renal function | CT iodinated contrast dye
Item
kidney function sufficient to tolerate iodine-based ct contrast.
boolean
C0232804 (UMLS CUI [1])
C0040405 (UMLS CUI [2,1])
C0879373 (UMLS CUI [2,2])
Iodine contrast allergy Absent
Item
no allergy to iodine-based contrast.
boolean
C4022917 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Informed Consent
Item
ability to understand and the willingness to sign informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Radiotherapy to thorax
Item
participants with a prior history of thoracic radiotherapy.
boolean
C4038705 (UMLS CUI [1])
Investigational New Drugs
Item
participants may not be receiving any other study agents.
boolean
C0013230 (UMLS CUI [1])
CT scan contrast Receive Unable
Item
inability to tolerate ct contrast
boolean
C0742919 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
Pregnancy | Breast Feeding To be stopped
Item
pregnant women are excluded from this study because radiotherapy has the potential for teratogenic or abortifacient effects. because there is an unknown but potential risk of adverse events in nursing infants secondary to treatment of the mother with radiotherapy, breastfeeding should be discontinued if the mother is treated with radiotherapy. these potential risks may also apply to other agents used in this study.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2,1])
C1272691 (UMLS CUI [2,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial